Pathfinder Cell Therapy, Inc.

PFND · OTC
Analyze with AI
9/30/2015
6/30/2015
3/31/2015
12/31/2014
Operating Activities
Net Income-$289-$222-$276-$293
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$110$123$99$166
Other Non-Cash$3$44$50$41
Operating Cash Flow-$178-$98-$176-$127
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$182$77$171$130
Financing Cash Flow$182$77$171$130
Forex Effect$0$0$0$0
Net Chg. in Cash$4-$21-$5$3
Supplemental Information
Beg. Cash$0$21$26$23
End Cash$4$0$21$26
Free Cash Flow-$178-$98-$176-$127
Pathfinder Cell Therapy, Inc. (PFND) Financial Statements & Key Stats | AlphaPilot